In the chronic phase of EAE model mice, enrichment of CD4+ TRM with a pro‐inflammatory phenotype was observed, and it was found that CD4+ TRM accumulates in inflammatory lesions in the brains of individuals with progressive MS. The gene discussed is CD4; the disease is myeloid sarcoma.